Related Experiment Videos
Characterization of the epidermal-growth-factor-dependent phosphorylation system from normal mouse-liver sinusoidal
Abstract:
Blood sinusoidal plasma membrane subfractions were isolated from normal mouse liver in the presence of the proteinase inhibitors PhMeSO2F and iodoacetamide. They were purified from smooth microsomal and Golgi vesicle contaminants. The phosphorylation reaction was studied at 33 degrees C, in the presence of 2 mM MnCl2. Addition of epidermal growth factor (EGF) to the preparations stimulated 32P incorporation from [gamma-32P]ATP or [gamma-32P]GTP essentially into one 170 000 Mr protein. Some incorporation was observed in a minor 120 000-Mr component which appears to be a degradation product of the 170 000-Mr component. No EGF-dependent phosphorylation of other membrane proteins or various exogenous proteins could be detected in vitro. The dephosphorylation of the 170 000-Mr component was observed after 4 min of incubation at 33 degrees C. This dephosphorylation reaction was inhibited by addition of 5 mM p-nitrophenyl phosphate but not by addition of micromolar Zn2+, Be2+ or orthovanadate. The 170 000-Mr protein specifically bound 125I-labeled EGF and thus appeared to be the hepatic EGF receptor. The EGF stimulatable kinase activity considerably enhances incorporation of 32P into tyrosine residues of the 170 000-Mr EGF receptor at 33 degrees C. Tryptic peptide maps of the 32P-labeled 170 000-Mr protein revealed a multiplicity of phosphorylated sites. Seven 32P-labeled phosphopeptides were observed after EGF stimulation, three of them being largely prominent. Tryptic peptide maps of the 170 000-Mr protein after it was covalently linked to 125I-labeled EGF showed only one 125I-labeled peptide, the migration of which appeared different from that of 32P-labeled phosphopeptides. These findings were confirmed by V8 protease unidimensional peptide mapping of the 170 000-Mr protein, labeled with 32P or 125I-EGF.
Insights
This study identifies the 170,000 Mr protein in mouse liver plasma membranes as the epidermal growth factor (EGF) receptor. EGF stimulation enhances its tyrosine phosphorylation, confirming its role as an EGF-regulatable kinase.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- The epidermal growth factor (EGF) receptor plays a crucial role in cellular signaling pathways.
- Understanding the biochemical properties of the EGF receptor is essential for deciphering its function.
Purpose of the Study:
- To isolate and characterize the protein responsible for epidermal growth factor (EGF) binding and phosphorylation in mouse liver sinusoidal plasma membranes.
- To investigate the kinase activity associated with the hepatic EGF receptor.
Main Methods:
- Isolation of mouse liver sinusoidal plasma membrane subfractions.
- In vitro phosphorylation assays using [gamma-32P]ATP or [gamma-32P]GTP.
- Binding studies with 125I-labeled EGF.
- Analysis of phosphorylation sites using tryptic peptide mapping and V8 protease mapping.
Main Results:
- A 170,000 Mr protein was identified as the specific binding site for 125I-labeled EGF.
- EGF stimulation significantly enhanced 32P incorporation into tyrosine residues of the 170,000 Mr protein.
- Peptide mapping revealed multiple phosphorylation sites on the EGF receptor.
- Dephosphorylation of the 170,000 Mr protein was observed and could be inhibited by p-nitrophenyl phosphate.
Conclusions:
- The 170,000 Mr protein is the hepatic EGF receptor, possessing intrinsic EGF-stimulatable kinase activity.
- The receptor undergoes phosphorylation primarily on tyrosine residues upon EGF binding.
- These findings elucidate key aspects of EGF receptor function in liver cells.